A5082954836- Pharmaceutical Practices and Patient Outcomes
- Patient Safety and Medication Errors
- Pharmaceutical studies and practices
- Cancer Treatment and Pharmacology
- Complementary and Alternative Medicine Studies
- Pharmacovigilance and Adverse Drug Reactions
- Herbal Medicine Research Studies
- Healthcare Technology and Patient Monitoring
HES-SO University of Applied Sciences and Arts Western Switzerland
2023
University of Geneva
2023
University Hospital of Geneva
2019-2022
Abstract Complementary medicine (CM) is used by one third to half of cancer patients throughout the world. The objective this study was describe prevalence CM use and potential for interactions with treatments in an academic oncology centre. A cross-sectional conducted among undergoing current treatment. Among 132 included patients, 56% had since their diagnosis 45% were using during treatment at time survey. main green tea (35%), herbal homeopathy (27%), dietary supplements medicines (27%)....
Abstract Background Adverse drug events contribute to rising health care costs. Clinical pharmacists can reduce their risks by identifying and solving drug-related problems (DRPs) through medication review. Aim To develop an economic model determine whether reviews performed clinical could lead a reduction in costs associated with the prevention of potential adverse events. Method Two during ward rounds internal medicine setting over one year. Avoided were estimated monetizing five...
Abstract Background Adverse drug events (ADEs) can be prevented by deploying clinical decision support systems (CDSS) that directly assist physicians, via computerized order entry systems, and pharmacists performing medication reviews as part of medical rounds. However, physicians using CDSS are known to exposed the alert-fatigue phenomenon. Our study aimed assess performance PharmaCheck—a help detect high-risk situations with potential lead ADEs—and its impact on pharmacists’ activities....
Abstract Backgrounds: Adverse drug events (ADEs) contribute to rising healthcare costs. Clinical pharmacists can reduce the risks of ADEs by preventing medication errors (MEs) through therapy optimization. Aim: To build an economic model reveal whether clinical pharmacists’ review (MR) activities were compensated a reduction in costs associated with prevention potential ADEs. Method: Pharmacists performed MR solving drug-related problems (DRPs) prevent during ward rounds internal medicine...
Abstract Background: Adverse drug events (ADEs) can be prevented by deploying clinical decision support systems (CDSS) that directly assist physicians, via computerized order entry systems, and pharmacists performing medication reviews as part of medical rounds. However, physicians using CDSS are known to exposed the alert-fatigue phenomenon. Our study aimed assess performance PharmaCheck—a help detect high-risk situations with potential lead ADEs—and its impact on pharmacists’...